arrow
T

Tomoyoshi Shibuya

Juntendo University
H指数:25
被引数:2,618

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Antibiotic-Fecal Microbiota Transplantation for Ulcerative Colitis: A Multicenter Clinical Study in Japan

抗生素联合粪菌移植治疗溃疡性结肠炎的疗效与安全性:一项日本多中心临床研究

2025-12-010
PRE
Hydrogen Gas Inhalation Improved Intestinal Microbiota in Ulcerative Colitis: A Randomised Double-Blind Placebo-Controlled Trial

氢气吸入改善了溃疡性结肠炎患者的肠道微生物群:一项随机双盲安慰剂对照试验

2025-08-210
PRE
Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus < 70 Years With Ulcerative Colitis: Multicenter Retrospective Study

溃疡性结肠炎患者中≥70岁与<70岁患者接受维多利珠单抗治疗的实际有效性与安全性:多中心回顾性研究

2025-05-150
OA
Patient-donor similarity and donor-derived species contribute to the outcome of fecal microbiota transplantation for ulcerative colitis

患者-供体相似性和供体来源的物种有助于溃疡性结肠炎的粪便微生物移植结果

2025-04-010
PRE
DONOR-DERIVED GUT MICROBIOTA INFLUENCE THE EFFICACY OF COMBINATION WITH FMT AND MULTIPLE ANTIBIOTICS THERAPY FOR ULCERATIVE COLITIS

供者源性肠道微生物群影响联合粪菌移植和多种抗生素疗法治疗溃疡性结肠炎的疗效

2025-02-280
PRE
Factors affecting 1-year persistence with vedolizumab for ulcerative colitis: a multicenter, retrospective real-world study

影响维多珠单抗治疗溃疡性结肠炎1年持续性的因素: 一项多中心、回顾性真实世界研究

2025-01-160
OA
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study (DEC, 10.1007/s00535-024-02176-x, 2024)
2024-12-270
OAAI
Anti-integrin αvβ6 antibody as a biomarker for diagnosing ulcerative colitis: a nationwide multicenter validation study

抗整合素αvβ6抗体作为诊断溃疡性结肠炎的生物标志物:一项全国多中心验证研究

2024-11-281
OA
Comparative Efficacy and Safety of Three Janus Kinase Inhibitors in Ulcerative Colitis: A Real-World Multicentre Study in Japan
2024-11-222
PRE
Efficacy and safety of filgotinib for ulcerative colitis: A real-world multicenter retrospective study in Japan
2024-03-1712
PRE